Abstract

The aim of this study was to research the impact of inpatient rehabilitation on work ability and health-related quality of life factors for healthcare personnel (HP) with chronic hepatitis B and C virus (HBV and HCV) infection. A prospective evaluation study with three data collection times without an external control group was conducted. HP (n = 163) with an occupational acquired chronic hepatitis B/C infection who participated in an inpatient rehabilitation program were surveyed. Information was collected on work ability (WAI—Work Ability Index), quality of life (SF-36—Short Form-36 Health Survey), and anxiety and depression-related symptoms (HADS-D—Hospital Anxiety and Depression Scale). The majority of participants had HCV infection. Work ability was poor, improved significantly until the end of treatment, and remained at a moderate level six months later. The SF-36 showed no change in physical health over the study period, the results regarding mental health were in the average range with a significant improvement directly after intervention. The HADS-D results indicate noteworthy anxiety and depression symptoms during the study period. The inpatient rehabilitation program proved to be effective in the short term regarding mental health (SF-36) and WAI. To ensure long lasting positive results, services aimed at enhancing physical and mental health should be provided as early as possible and on a recurring basis.

Highlights

  • Hepatitis B and C virus (HBV and HCV) infections are among the most common blood-borne infectious diseases in the world

  • Healthcare personnel (HP) with a chronic HBV/HCV infection recognised as an occupational disease who participated in a four-week inpatient rehabilitation program at the Wartenberg Clinic between

  • 245 insured persons with chronic viral hepatitis participated in the treatment program at the Wartenberg Clinic

Read more

Summary

Introduction

Hepatitis B and C virus (HBV and HCV) infections are among the most common blood-borne infectious diseases in the world. According to recent estimates from the World Health Organisation (WHO), 3% of the world’s population (around 240 million) suffers from a chronic HBV infection, while. 1% (around 71 million) suffers from a chronic HCV infection [1,2]. These infections have potentially severe progressions that can result in work incapacity and mortality. In up to 10% of HBV and 85% of HCV cases, the infection is chronic. Chronic HBV and HCV infections are among the most significant causes of hepatic cirrhosis and hepatocellular carcinoma [3,4].

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call